Basilea Pharmaceutica AG (BSLN) — Cash Flow-to-Debt Ratio
Basilea Pharmaceutica AG (BSLN) has a Cash Flow-to-Debt Ratio of 0.25x as of December 2025, meaning its operating cash flow of CHF39.03 Million could theoretically repay 0% of its total liabilities (CHF154.06 Million) in one year. See Basilea Pharmaceutica AG free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Basilea Pharmaceutica AG Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Basilea Pharmaceutica AG across 24 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Basilea Pharmaceutica AG.
Annual Cash Flow-to-Debt Ratio for Basilea Pharmaceutica AG (2002–2025)
Year-by-year debt coverage analysis for Basilea Pharmaceutica AG. Check how high is Basilea Pharmaceutica AG's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.40x | CHF62.09 Million | CHF154.06 Million | ▼ -4.2% |
| 2024 | 0.42x | CHF74.36 Million | CHF176.76 Million | ▲ +441.3% |
| 2023 | 0.08x | CHF14.24 Million | CHF183.29 Million | ▲ +166.1% |
| 2022 | 0.03x | CHF7.06 Million | CHF241.56 Million | ▲ +127.9% |
| 2021 | -0.10x | CHF-32.02 Million | CHF305.87 Million | ▲ +35.8% |
| 2020 | -0.16x | CHF-54.13 Million | CHF331.84 Million | ▲ +19.6% |
| 2019 | -0.20x | CHF-63.84 Million | CHF314.43 Million | ▲ +10.7% |
| 2018 | -0.23x | CHF-79.21 Million | CHF348.44 Million | ▼ -569.4% |
| 2017 | 0.05x | CHF19.01 Million | CHF392.61 Million | ▲ +123.4% |
| 2016 | -0.21x | CHF-75.00 Million | CHF362.76 Million | ▼ -17.1% |
| 2015 | -0.18x | CHF-67.78 Million | CHF383.88 Million | ▲ +50.7% |
| 2014 | -0.36x | CHF-71.46 Million | CHF199.45 Million | ▼ -37.9% |
| 2013 | -0.26x | CHF-59.47 Million | CHF228.88 Million | ▼ -147.3% |
| 2012 | 0.55x | CHF148.17 Million | CHF269.84 Million | ▲ +155.9% |
| 2011 | -0.98x | CHF-82.38 Million | CHF83.82 Million | ▼ -198.0% |
| 2010 | 1.00x | CHF106.64 Million | CHF106.30 Million | ▲ +195.4% |
| 2009 | -1.05x | CHF-114.51 Million | CHF108.88 Million | ▼ -6.2% |
| 2008 | -0.99x | CHF-127.17 Million | CHF128.38 Million | ▼ -58.4% |
| 2007 | -0.63x | CHF-78.99 Million | CHF126.34 Million | ▲ +21.7% |
| 2006 | -0.80x | CHF-72.47 Million | CHF90.78 Million | ▼ -303.6% |
| 2005 | 0.39x | CHF34.38 Million | CHF87.69 Million | ▲ +112.9% |
| 2004 | -3.03x | CHF-64.20 Million | CHF21.18 Million | ▲ +3.3% |
| 2003 | -3.13x | CHF-52.42 Million | CHF16.73 Million | ▼ -22.9% |
| 2002 | -2.55x | CHF-64.07 Million | CHF25.13 Million | — |